Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,965 public trials 714 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Active, Not Recruiting

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

NCT03604198

Conditions
ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Cortex Diseases, +30 more
Locations
  • Site 49 Phoenix, Arizona, United States
  • Site 35 Stanford, California, United States
  • Site 39 Torrance, California, United States
  • Site 50 Miami, Florida, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

NCT07220759

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
Locations
  • Univ of Alabama_Birmingham Birmingham, Alabama, United States
  • Chambliss Clinical Trials, LLC Montgomery, Alabama, United States
  • Elite Clinical Network - Tucson Tucson, Arizona, United States
  • Scripps Whittier Diabetes Inst La Jolla, California, United States
View all 67 locations
View Trial Details
Active, Not Recruiting

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT06972472

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
Locations
  • Clinical Research Institute of Arizona (CRI) - Sun City West Sun City West, Arizona, United States
  • Novak Clinical Research - Tucson - North La Cholla Boulevard Tucson, Arizona, United States
  • Norcal Endocrinology & Internal Medicine San Ramon, California, United States
  • Southern California Clinical Research Santa Ana, California, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

NCT06260722

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • University of Alabama - Department of Nutrition Sciences Birmingham, Alabama, United States
  • Neighborhood Healthcare Institute of Health Escondido, California, United States
  • Long Beach Research Institute Long Beach, California, United States
  • Valley Clinical Trials, Inc. Northridge, California, United States
View all 77 locations
View Trial Details

Related conditions